D.Pharm Pharmacy at Vinayaka Mission's Research Foundation VMRF Salem is a 2 Years Diploma. The course is offered On Campus as a Full Time program. Vinayaka Mission's Research Foundation VMRF Salem D.Pharm Pharmacy First Year Fees is INR 50,000 for 2025.
Vinayaka Mission's Research Foundation VMRF Salem offers a total of 120 seats for D.Pharm Pharmacy. Candidates must have at least 10+2 to be eligible for admissions.
According to NIRF Rankings 2024 for Pharmacy, Vinayaka Mission's Research Foundation VMRF Salem ranks 89 out of 125 in India.
| Fees (2025 - 2026) | Year 1 (in INR) | Year 2 (in INR) |
|---|---|---|
| Tuition Fees | 50000 | 50000 |
| Yearly Fees | 50000 | 50000 |
* Fees is refundable
| Fees | Year 1 (in INR) | Year 2 (in INR) |
|---|---|---|
| Tuition Fees | 50000 | 50000 |
| Other Fee | 500 | - |
| Yearly Fees | 50500 | 50000 |
* Fees is refundable
The minimum eligibility for admission to D.Pharm Pharmacy at Vinayaka Mission's Research Foundation VMRF Salem is 10+2.
Vinayaka Mission's Research Foundation VMRF Salem ranking 2025 has not been released. You can check the agency wise previous year national ranking below.
| Ranking Agency | Latest | |
|---|---|---|
![]() | #89 out of 125 (2024) #12th Tamil Nadu | |
Also Check:
| Course Highlights | Details |
|---|---|
| duration | 2 Years (Full Time) |
| course level | UG Diploma (Diploma) |
| mode of study | On Campus |
| total fees | ₹ 1 Lakh |
| eligibility | 10+2 |
| Fee Type | Total Amount (INR) |
|---|---|
| tuition fee | ₹1 Lakh |
| total academic fee | ₹1 Lakh |
| hostel fee | ₹1.79 Lakhs |
| total fee | ₹2.79 Lakhs |
| Events | Dates |
|---|---|
| Reporting Time for Tamil Nadu NEET [Pharm.D] (PB) | Oct 18, 2025 |
| Final result of 1st Round Allotment for Tamil Nadu NEET [Pharm.D] (PB) | Oct 13, 2025 |
| Download Provisional Allotment Order for Tamil Nadu NEET [Pharm.D] (PB) | Oct 13, 2025 |
Do you think the Dates are wrong ? Report Here
Search from 20K+ Courses and 35+ Streams
Do you think the data is wrong ? Report Here
.png?h=78&w=78&mode=stretch)


















Comments